CS318690A3 - Pharmaceutical composition usable for depression therapy - Google Patents

Pharmaceutical composition usable for depression therapy

Info

Publication number
CS318690A3
CS318690A3 CS903186A CS318690A CS318690A3 CS 318690 A3 CS318690 A3 CS 318690A3 CS 903186 A CS903186 A CS 903186A CS 318690 A CS318690 A CS 318690A CS 318690 A3 CS318690 A3 CS 318690A3
Authority
CS
Czechoslovakia
Prior art keywords
pharmaceutical composition
composition usable
depression therapy
depression
therapy
Prior art date
Application number
CS903186A
Other languages
English (en)
Inventor
Nobuyoshi Iwata
Kenji Yoshimi
Mitauo Nagano
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21560789A external-priority patent/JP2786684B2/ja
Priority claimed from JP26470689A external-priority patent/JP2786695B2/ja
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of CS318690A3 publication Critical patent/CS318690A3/cs
Publication of CZ277776B6 publication Critical patent/CZ277776B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS903186A 1989-06-26 1990-06-26 Pharmaceutical composition usable for depression therapy CZ277776B6 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16294089 1989-06-26
JP21560789A JP2786684B2 (ja) 1989-08-22 1989-08-22 イソオキサゾール化合物を有効成分とする抗うつ剤
JP26470689A JP2786695B2 (ja) 1989-10-11 1989-10-11 ベンゾイソオキサゾリン―3―オン誘導体を含有する抗うつ剤

Publications (2)

Publication Number Publication Date
CS318690A3 true CS318690A3 (en) 1992-11-18
CZ277776B6 CZ277776B6 (en) 1993-04-14

Family

ID=27322089

Country Status (15)

Country Link
US (1) US5116839A (cs)
EP (1) EP0405905B1 (cs)
KR (1) KR910000141A (cs)
CN (1) CN1049100A (cs)
AT (1) ATE131054T1 (cs)
CA (1) CA2019259A1 (cs)
CZ (1) CZ277776B6 (cs)
DE (1) DE69023964T2 (cs)
DK (1) DK0405905T3 (cs)
ES (1) ES2083428T3 (cs)
GR (1) GR3018535T3 (cs)
HU (1) HU206263B (cs)
IE (1) IE71939B1 (cs)
PT (1) PT94480B (cs)
RU (1) RU2058778C1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108448T1 (de) * 1990-05-11 1994-07-15 Sankyo Co Piperdinyloxy- und chinindidinyloxy- isoxazol- derivate, ihre herstellung und ihre therapeutische verwendung.
DE19513503A1 (de) * 1995-04-10 1996-10-17 Kali Chemie Pharma Gmbh (Phenylalkylaminoalkyloxy)-heteroaryl-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NZ291508A (en) * 1994-08-30 1999-07-29 Sankyo Co Isoxazoles; preparation and medicaments
CA2247439A1 (en) * 1996-02-27 1997-09-04 Sankyo Company, Limited Isoxazole derivatives
ATE315033T1 (de) 1998-08-07 2006-02-15 Chiron Corp Subtituierte isoxazole derivate als estrogen rezeptor modulatore

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4867275A (cs) * 1971-12-21 1973-09-13
JPS53157925U (cs) * 1977-05-18 1978-12-11
JPS58194869A (ja) * 1982-05-10 1983-11-12 Sankyo Co Ltd イソオキサゾリノン誘導体及び殺虫・殺ダニ剤
IE60267B1 (en) * 1986-12-26 1994-06-29 Sankyo Co Centrally-acting muscle relaxants
DE68915595T2 (de) * 1988-03-24 1994-09-15 Sankyo Co Verwendung von Isoxazolinonen als cerebro-aktive Medikamente.
IE62276B1 (en) * 1988-03-30 1995-01-25 Sankyo Co "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants"

Also Published As

Publication number Publication date
ATE131054T1 (de) 1995-12-15
PT94480A (pt) 1991-02-08
IE902286L (en) 1990-12-26
CZ277776B6 (en) 1993-04-14
CA2019259A1 (en) 1990-12-26
HUT59311A (en) 1992-05-28
EP0405905A3 (en) 1992-01-02
RU2058778C1 (ru) 1996-04-27
US5116839A (en) 1992-05-26
EP0405905A2 (en) 1991-01-02
CN1049100A (zh) 1991-02-13
HU206263B (en) 1992-10-28
HU903996D0 (en) 1990-11-28
DE69023964T2 (de) 1996-08-14
KR910000141A (ko) 1991-01-29
DK0405905T3 (da) 1996-04-15
ES2083428T3 (es) 1996-04-16
IE902286A1 (en) 1991-01-16
IE71939B1 (en) 1997-03-12
EP0405905B1 (en) 1995-12-06
PT94480B (pt) 1996-12-31
DE69023964D1 (de) 1996-01-18
GR3018535T3 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
TW249226B (cs)
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
SE9704546D0 (sv) Novel compounds
EP0328251A3 (en) 2-(2-hydroxy-3-phenoxypropylamino)ethylphenoxyacetamides and processes and intermediates for their preparation
CA2030345A1 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
FI874660A7 (fi) Aine hammasjäljennöksiä varten.
AU3354895A (en) Novel medicinal use of 5ht3 antagonist
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
ZA884418B (en) Pharmaceutical dosage unit
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
SE8900875L (sv) Osteoporosbehandling
IE902286L (en) Use of isoxazolin-3-one derivatives as antidepressants
HU9301992D0 (en) New phospholipid derivatives
IL95245A0 (en) Pharmaceutical compositions containing a certain carbazolone for the treatment of bulimia
EP0261439A3 (en) Medicament for curing arteriosclerosis, comprising pyrimido (2,1-b) benzothiazole derivative
DK256689A (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv